Author: Barth, Stefan
Similar Items: Development and Characterization of recombinant immunotoxins for cervical carcinoma
- Development of recombinant immunotoxins targeting overexpressed cell surface biomarkers trophoblast cell-surface antigen 2 and mesothelin for cervical cancer treatment
- Characterization of ADAM10 in cervical and oesophageal cancers
- Development Of Recombinant Immunotherapeutics for Triple-Negative Breast Cancer (TNBC)
- Simulating recombinant sequence date to evaluate and improve computational methods of multiple sequence alignment and recombinant identification
- Late radiation proctitis : the incidence and contributing factors in patients with locally advanced cervical carcinoma treated at Pretoria Academic Hospital
- Molecular characterization of the A52 murine hepatocellular carcinoma cell line